Literature DB >> 20497162

A thermoreversible polymer mediates controlled release of glial cell line-derived neurotrophic factor to enhance kidney regeneration.

Yousof Gheisari1, Takashi Yokoo, Kei Matsumoto, Akira Fukui, Naomi Sugimoto, Toya Ohashi, Tetsuya Kawamura, Tatsuo Hosoya, Eiji Kobayashi.   

Abstract

Previously, we reported that human mesenchymal stem cells (hMSCs) that were cultivated in growing embryos differentiated in an appropriate developmental milieu, thereby facilitating the development of a functional renal unit. However, this approach required transfection with an adenovirus that expressed glial cell line-derived neurotrophic factor (GDNF) to enhance the development of hMSC-derived renal tissue, and safety issues restrict the clinical use of such viral vectors. To circumvent this problem, we tested an artificial polymer as a means to diffuse GDNF. This GDNF-polymer, which exists in liquid form at 4 degrees C but becomes a hydrogel upon heating to 37 degrees C, was used as a thermoreversible switch, allowing the injection of hMSCs at low viscosity using a mouth pipette, with subsequent slow diffusion of GDNF as it solidified. The polymer, which was dissolved in a solution of GDNF at 4 degrees C and then maintained at 37 degrees C, acted as a diffuser of GDNF for more than 48 h. LacZ-transfected hMSCs and the GDNF-polymer (at 4 degrees C) were placed in the nephrogenic sites of growing rat embryos that were maintained at 37 degrees C. Forty-eight hours later, the resultant kidney anlagen were dissected out and allowed to continue developing for 6 days in vitro. Whole-organ X-Gal staining and fluorescence activated cell sorter analysis showed that the number of hMSC-derived cells was significantly increased in developed anlagen that have been generated from hMSCs plus GDNF-polymer compared with those from hMSCs plus GDNF-containing medium and was comparable to those from adenovirus-transfected hMSCs. These findings suggest that the GDNF-polymer can be used as a diffuser of GDNF for kidney organogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20497162     DOI: 10.1111/j.1525-1594.2009.00928.x

Source DB:  PubMed          Journal:  Artif Organs        ISSN: 0160-564X            Impact factor:   3.094


  7 in total

1.  Immunotherapy with injectable hydrogels to treat obstructive nephropathy.

Authors:  Danielle E Soranno; Hoang D Lu; Heather M Weber; Reena Rai; Jason A Burdick
Journal:  J Biomed Mater Res A       Date:  2013-08-08       Impact factor: 4.396

2.  Potential use of stem cells for kidney regeneration.

Authors:  Takashi Yokoo; Kei Matsumoto; Shinya Yokote
Journal:  Int J Nephrol       Date:  2011-04-12

Review 3.  Current Bioengineering Methods for Whole Kidney Regeneration.

Authors:  Shuichiro Yamanaka; Takashi Yokoo
Journal:  Stem Cells Int       Date:  2015-05-18       Impact factor: 5.443

Review 4.  Special Morphological Features at the Interface of the Renal Stem/Progenitor Cell Niche Force to Reinvestigate Transport of Morphogens During Nephron Induction.

Authors:  Will W Minuth; Lucia Denk
Journal:  Biores Open Access       Date:  2016-01-01

5.  Generation of interspecies limited chimeric nephrons using a conditional nephron progenitor cell replacement system.

Authors:  S Yamanaka; S Tajiri; T Fujimoto; K Matsumoto; S Fukunaga; B S Kim; H J Okano; T Yokoo
Journal:  Nat Commun       Date:  2017-11-23       Impact factor: 14.919

Review 6.  De novo kidney regeneration with stem cells.

Authors:  Shinya Yokote; Shuichiro Yamanaka; Takashi Yokoo
Journal:  J Biomed Biotechnol       Date:  2012-11-26

Review 7.  Concepts for a therapeutic prolongation of nephrogenesis in preterm and low-birth-weight babies must correspond to structural-functional properties in the nephrogenic zone.

Authors:  Will W Minuth
Journal:  Mol Cell Pediatr       Date:  2017-12-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.